+91-80-26860424 / 34

Call Us Today

LinkedIn

Search
 

Filing of Pharmaceutical patents Tag

BananaIP Counsels > Posts tagged "Filing of Pharmaceutical patents"

A Patently Generic Win

This post was first published on April 23, 2012. In a landmark decision on a generic drug-maker’s ability to introduce a generic drug for uses not indicated on the branded product’s label, the US Supreme Court ruled in favour of Caraco Pharmaceutical Laboratories, a unit of Sun Pharmaceutical Industries, in its patent litigation against Novo Nordisk over Caraco’s generic version of Prandin, repaglinide tablets, a blood glucose lowering drug. The drug in question, Prandin, generically known as repaglinide, is used for treatment of Type-2 diabetes. The drug is approved for three different uses, out of which Novo had valid patent on one....

Continue reading

Roche’s backbone rendered brittle by Indian Patent Office

This image depicts the logo of Hoffmann-La-Roche’s, a pharmaceutical Giant. This image is relevant as it Roche had a filed for a patent for its Drug intended to cure Osteoporosis. Click on the image for more information

The Chennai Patent Office revoked Hoffmann-La-Roche’s patent on its osteoporosis drug, Bonviva, in response to post grant opposition filed by Indian drug maker, Cipla Global Ltd. The drug in question comprises Ibandronate Sodium, used to treat patients suffering from metastatic cancer, associated skeletal fractures and osteoporosis and also for the treatment and prevention of osteoporosis in post-menopausal women. Osteoporosis is the progressive bone disease caused by decrease in bone mass making bones extremely weak and fragile, leading to increased risk of fractures.  The drug is marketed as Boniva in the US, Bondronat in Europe and Bonviva in Asia. The patent in dispute...

Continue reading
Speak with an IP Expert Today
close slider
css.php